Chongqing BDSyn Biotechnology Co., Ltd.
BDSyn Bio is an innovative biotechnology company specializing in the research, development, and production of vaccine adjuvants. With outstanding adjuvant industrialization technologies, the company has successfully developed structurally defined QS-21 Api & QS-21 Xyl and monophosphoryl lipid A (MPL) series products. It supplies both traditional adjuvants (e.g., aluminum hydroxide) and novel adjuvant systems (e.g., BDS01–BDS08). Committed to technological innovation, BDSyn is dedicated to delivering high-performance and safe adjuvant solutions for global vaccine manufacturers.